PTC Therapeutics Inc (PTCT)
43.63
+0.74
(+1.73%)
USD |
NASDAQ |
Nov 22, 15:30
PTC Therapeutics Total Liabilities (Quarterly): 2.897B for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 2.897B |
| June 30, 2024 | 2.897B |
| March 31, 2024 | 2.684B |
| December 31, 2023 | 2.714B |
| September 30, 2023 | 1.931B |
| June 30, 2023 | 1.917B |
| March 31, 2023 | 2.066B |
| December 31, 2022 | 2.053B |
| September 30, 2022 | 1.803B |
| June 30, 2022 | 1.986B |
| March 31, 2022 | 1.890B |
| December 31, 2021 | 1.937B |
| September 30, 2021 | 1.902B |
| June 30, 2021 | 1.862B |
| March 31, 2021 | 1.819B |
| December 31, 2020 | 1.726B |
| September 30, 2020 | 1.670B |
| June 30, 2020 | 904.14M |
| March 31, 2020 | 1.017B |
| December 31, 2019 | 1.029B |
| September 30, 2019 | 977.83M |
| June 30, 2019 | 802.89M |
| March 31, 2019 | 770.97M |
| December 31, 2018 | 768.50M |
| Date | Value |
|---|---|
| September 30, 2018 | 642.54M |
| June 30, 2018 | 244.37M |
| March 31, 2018 | 229.10M |
| December 31, 2017 | 235.22M |
| September 30, 2017 | 221.84M |
| June 30, 2017 | 213.35M |
| March 31, 2017 | 147.82M |
| December 31, 2016 | 149.76M |
| September 30, 2016 | 148.00M |
| June 30, 2016 | 139.94M |
| March 31, 2016 | 139.23M |
| December 31, 2015 | 139.28M |
| September 30, 2015 | 126.95M |
| June 30, 2015 | 25.24M |
| March 31, 2015 | 26.20M |
| December 31, 2014 | 34.75M |
| September 30, 2014 | 19.50M |
| June 30, 2014 | 13.80M |
| March 31, 2014 | 11.50M |
| December 31, 2013 | 15.36M |
| September 30, 2013 | 16.21M |
| June 30, 2013 | 22.55M |
| March 31, 2013 | 30.33M |
| December 31, 2012 | 32.27M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
904.14M
Minimum
Jun 2020
2.897B
Maximum
Sep 2024
1.935B
Average
1.910B
Median
Total Liabilities (Quarterly) Benchmarks
| ClearPoint Neuro Inc | 11.19M |
| Pfizer Inc | 126.92B |
| Vertex Pharmaceuticals Inc | 6.609B |
| BridgeBio Pharma Inc | 1.883B |
| Cassava Sciences Inc | 57.11M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.842B |
| Shareholders Equity (Quarterly) | -1.054B |
| Debt to Equity Ratio | -0.2704 |
| Current Ratio | 2.098 |
| Net Debt Paydown Yield | 2.01% |